Stockreport

GondolaBio and n-Lorem Foundation Partner to Advance Novel ASO Therapies for Genetic Diseases [Yahoo! Finance]

BridgeBio Pharma, Inc.  (BBIO) 
Last bridgebio pharma, inc. earnings: 3/2 08:29 am Check Earnings Report
PDF GondolaBio is a clinical-stage biotechnology company founded in September 2024 with $300 million in backing from investors, including Patient Square Capital, Viking Glo [Read more]